Science Explorer Back to mapMap
Discussion
Topic · Dermatology

Cancer and Skin Lesions

Cancer and Skin Lesions is a research topic within Dermatology. Science Explorer counts 29k research works in it since 1950. 10.2% of them reached the world's top 10% most cited for their field and year.

This cluster of papers focuses on the study of cutaneous adnexal neoplasms, including topics such as extramammary Paget's disease, cylindromatosis gene mutations, Mohs micrographic surgery, and the use of immunohistochemistry in diagnosis. It also covers related syndromes and molecular markers associated with these neoplasms.

  • Extramammary Paget's Disease
  • Adnexal Neoplasms
  • Paget's Disease
  • Cylindromatosis Gene
  • Mohs Micrographic Surgery
  • Immunohistochemistry
  • Trichoepithelioma
  • Pilomatricoma
  • Sweat Gland Carcinoma
  • ß-Catenin Mutation
Research works
29k
fractional, since 1950
In the world top 10%
3k
per year above
Top-10% rate
10.2%
share of its works in the world top 10%
Growth, 2018-21 → 2022-25
-1%
the tick is no change
Largest producer
United States
31% of the 10 largest, 2022-now
Cancer and Skin Lesions

This ranks research output and citation impact. It says nothing about the quality of diagnosis, treatment or care.

Which countries lead Cancer and Skin Lesions research?

By volume, the United States and India publish the most (1k and 670 works in 2022-now).

By volume, 2022-now

  1. 1 United States 1k works
  2. 2 India 670 works
  3. 3 China 421 works
  4. 4 Japan 262 works
  5. 5 Spain 171 works
  6. 6 Italy 162 works
  7. 7 United Kingdom 151 works
  8. 8 Brazil 145 works
  9. 9 Germany 138 works
  10. 10 Türkiye 116 works

How concentrated that is

The same countries as shares of everything the list above accounts for. A node where two countries do two thirds of the work and one spread evenly across twelve read alike as a ranking and not at all alike here.

United States: 31.4%India: 20.5%China: 12.9%Japan: 8.0%6 others listed: 27.1%31%largest
United States1,023 · 31.4%India670 · 20.5%China421 · 12.9%Japan262 · 8.0%6 others listed883 · 27.1%

Shares of the rows listed above, not of the whole node.

Which institutions lead Cancer and Skin Lesions research?

By volume in 2022-now, All India Institute of Medical Sciences publishes the most Cancer and Skin Lesions research, followed by Harvard University and Mayo Clinic.

By volume, 2022-now

  1. 1 All India Institute of Medical SciencesIndia 77 works
  2. 2 Harvard UniversityUnited States 35 works
  3. 3 Mayo ClinicUnited States 31 works
  4. 4 Banaras Hindu UniversityIndia 28 works
  5. 5 The University of Texas MD Anderson Cancer CenterUnited States 21 works
  6. 6 University of DelhiIndia 21 works
  7. 7 Centre Hospitalier Universitaire Hassan IIMorocco 17 works
  8. 8 Chinese Academy of Medical Sciences & Peking Union Medical CollegeChina 17 works
  9. 9 Memorial Sloan Kettering Cancer CenterUnited States 16 works
  10. 10 The Ohio State UniversityUnited States 16 works

Who are the leading researchers in Cancer and Skin Lesions?

The most-cited researchers publishing on Cancer and Skin Lesions include Walter Churchill Willett, Jost Bruno Jonas and Cyrus Cooper.

  1. 1 Walter Churchill Willett United States 411k citations
  2. 2 Jost Bruno Jonas Germany 350k citations
  3. 3 Cyrus Cooper United Kingdom 342k citations
  4. 4 Charles M. Perou United States 263k citations
  5. 5 Hans C. Clevers Netherlands 260k citations
  6. 6 Carlo La Vecchia Italy 258k citations
  7. 7 André Gerardus Uitterlinden Netherlands 246k citations

Ranked by citations received across their whole record, among researchers with at least three works on this topic.

What are the most cited papers in Cancer and Skin Lesions?

The most cited paper in Cancer and Skin Lesions is "Risk Factors for Breast Cancer in Women with Proliferative Breast Disease" (William D. Dupont, David L. Page, 1985), with 1,858 citations. Next come "Confocal Imaging–Guided Laser Ablation of Basal Cell Carcinomas: An Ex Vivo Study" (1,743) and "Skin Cancers after Organ Transplantation" (1,599).

Most cited papers
#PaperReleasedCitations
1 Risk Factors for Breast Cancer in Women with Proliferative Breast Disease William D. Dupont, David L. Page · New England Journal of Medicine 17 Jan 1985 1,858
2 Confocal Imaging–Guided Laser Ablation of Basal Cell Carcinomas: An Ex Vivo Study Heidy Sierra, Miguel A. Cordova, Chih‐Shan Jason Chen et al. · Journal of Investigative Dermatology Open access Sep 2014 1,743
3 Skin Cancers after Organ Transplantation Sylvie Euvrard, Jean Kanitakis, A Claudy · New England Journal of Medicine 23 Apr 2003 1,599
4 Controls of Hair Follicle Cycling Kurt S. Stenn, Ralf Paus · Physiological Reviews Review 2001 1,541
5 Efficacy and Safety of Vismodegib in Advanced Basal-Cell Carcinoma Aleksandar Sekulić, Michael Robert Migden, Anthony E. Oro et al. · New England Journal of Medicine Open access 7 Jun 2012 1,464
All 100 most cited papers, with filters and sorting

Where is Cancer and Skin Lesions research done?

The largest centres of Cancer and Skin Lesions research in 2022-now are New Delhi (India), Beijing (China), New York (United States) and Tokyo (Japan). Among places with at least 20 works in it, it is an unusually large share of all research in Fes, Rabat and Varanasi.

Largest cities, 2022-now

  1. 1 New DelhiIndia 87 works
  2. 2 BeijingChina 66 works
  3. 3 New YorkUnited States 56 works
  4. 4 TokyoJapan 51 works
  5. 5 ChennaiIndia 45 works
  6. 6 LondonUnited Kingdom 45 works
  7. 7 HoustonUnited States 44 works
  8. 8 ParisFrance 39 works
  9. 9 IstanbulTürkiye 39 works
  10. 10 ShanghaiChina 38 works

Where it is the local speciality

  1. FesMA · 26.0 works15×
  2. RabatMA · 23.1 works7.8×
  3. VaranasiIN · 28.5 works6.7×
← less than its size predicts1×more →

Location quotient: how much more of its research is in Cancer and Skin Lesions than the world average.

See Cancer and Skin Lesions on the map

Where is the best place to study Cancer and Skin Lesions?

Among universities, judged by research, Harvard University, University of Michigan and Université Libre de Bruxelles score highest, combining citation excellence, specialisation, size, growth and international reach. Research strength is one signal when choosing where to study; it does not measure teaching.

0%10%20%30%mean 20.06%fractional works in this field (log) →share of work in the world top 10% →Université Libre de …Harvard UniversityUniversity of MichiganAll India Institute …
above the meannear itbelow it

One dot per university in the first ten of the table below, at the default weights. The upper left is the interesting corner: small places doing unusually strong work.

Citation excellenceshare of its work in the world top 10%, 2022-now and all time averaged
40%
Specialisationhow much of its work is in this field, counted up to 10× the world share
10%
Sizeits output in this field, on a log scale
30%
Growthoutput growth, counted from -20% to +20%
10%
Internationalshare of its work with a co-author abroad
10%
Each slider sets a weight; the share it gets of the score is beside it.
#UniversityScoreTop 10%SpecialisationWorksGrowth
1Harvard UniversityUnited States 68.023.5%2.7×35 -29.3%
2University of MichiganUnited States 60.323.3%2.0×13 +16.6%
3Université Libre de BruxellesBelgium 59.727.5%6.4×8 +184.9%
4All India Institute of Medical SciencesIndia 54.22.8%16.9×77 +67.2%
5Università Cattolica del Sacro CuoreItaly 53.419.8%5.3×9 +31.7%
6Yale UniversityUnited States 52.319.4%2.9×13 -0.4%
7University of California, San FranciscoUnited States 51.019.2%3.0×9 +2.3%
8The Ohio State UniversityUnited States 50.417.6%3.2×16 +65.3%
9University of Southern CaliforniaUnited States 49.220.7%2.7×9 +79.1%
10Stanford UniversityUnited States 48.226.8%1.4×9 -28.9%

Universities only. The score blends citation excellence (40%), size (30%), specialisation (10%), growth (10%), international reach (10%), 2022-now; growth compares 2018-21 with 2022-25 and counts up to +20%, since a jump from a small base is mostly noise.

Every institution in Cancer and Skin Lesions, country by country

Is Cancer and Skin Lesions research growing?

Output in 2022-2025 was 1% lower than in 2018-2021, peaking in 2020.

still counting19801990200020102020
grewheldshrank

The same series as a ribbon: one cell per year, darker for more. The line above answers how much; this answers when.

Its share of all research

Growing output can still be a shrinking share: all of science grows. This is Cancer and Skin Lesions as a percentage of every work published that year, 0.021% in 2024.

still counting0.020%0.040%Cancer and Skin Lesions0.018% in 202519801990200020102020

Fractional works of Cancer and Skin Lesions over all fractional works that year. How the balance of science has shifted.

How much of it reaches the world top 10%

Year by year.

still counting5%10%15%Cancer and Skin Lesions10.1% in 2025200020102020

Of each year's works in it, the share that reached the world's 10% most cited for their field and year. A field is the world for its own topics, so there is no other line to hold it against.

Which topics inside it are moving

Growth and decline on one axis around a shared zero. Two lists side by side hide the thing that matters: whether the growth dwarfs the decline, or the other way round.

Discussion

Ask a question or share a note about Cancer and Skin Lesions. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.